Expertise in
1
conditions

Dr. Mirwais Saifi

Family Medicine
Brij Gupta MD Inc.
10158 Buena Vista Ave, 
Santee, CA 
Offers Telehealth
18 Years of Experience
Expertise in
1
conditions
Brij Gupta MD Inc.
10158 Buena Vista Ave, 
Santee, CA 

Overview

Mirwais Saifi is a primary care provider, practicing in Family Medicine in Santee, California. He has been practicing medicine for over 18 years.

Dr. Saifi is highly rated in 1 condition, according to our data. His clinical expertise encompasses Insomnia, Familial Hypertension, Hypertension, and Glucocorticoid-Remediable Aldosteronism.

He is actively involved in clinical research, participating in 5 clinical trials.

Graduate Year

2008

Specialties

Family Medicine

Licenses

Family Medicine in VA

Hospital Affiliations

Grossmont Hospital
Sharp Memorial Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Baylor Scott & White Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Community Health Group
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Santa Clara Family Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
South Country Health Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 19 Less Insurance Carriers -

Locations

Brij Gupta MD Inc.
10158 Buena Vista Ave, Santee, CA 92071

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Enrollment Status: Completed
Publish Date: November 05, 2025
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Phase 3, 16-week, Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Study to Assess the Impact of Lebrikizumab on Vaccine Responses in Adult Patients With Moderate-to-Severe Atopic Dermatitis
A Phase 3, 16-week, Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Study to Assess the Impact of Lebrikizumab on Vaccine Responses in Adult Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: October 17, 2023
Intervention Type: Drug
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate to Severe Atopic Dermatitis
A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: November 30, 2022
Intervention Type: Biological, Other
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Trial To Evaluate The Efficacy and Safety of Lebrikizumab When Used In Combination With Topical Corticosteroid Treatment In Patients With Moderate-To-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled Trial To Evaluate The Efficacy and Safety of Lebrikizumab When Used In Combination With Topical Corticosteroid Treatment In Patients With Moderate-To-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: May 09, 2022
Intervention Type: Other, Biological
Study Drugs: Lebrikizumab, Topical Corticosteroid
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate Efficacy, Pharmacokinetics, and Safety of Multiple Intravenous Doses of FB825 in Adults With Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate Efficacy, Pharmacokinetics, and Safety of Multiple Intravenous Doses of FB825 in Adults With Atopic Dermatitis
Enrollment Status: Unknown
Publish Date: April 04, 2022
Intervention Type: Biological, Other
Study Drug: FB825
Study Phase: Phase 2
View 4 Less Clinical Trials
Similar Doctors
Expertise in
90
conditions
Expertise in
90
conditions

El Cajon Family Health Center

525 E Main St, 
El Cajon, CA 
 (3.0 miles away)
619-515-2498
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Christopher Gordon is a primary care provider, practicing in Family Medicine in El Cajon, California. Dr. Gordon is highly rated in 90 conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, High Cholesterol, Obesity, and Intrauterine Device Insertion. Dr. Gordon is currently accepting new patients.

Expertise in
24
conditions
Dr. Ada M. Marin
Family Medicine
Expertise in
24
conditions
Dr. Ada M. Marin
Family Medicine

Metro Family Physicians Medical Group Inc.

5030 Camino De La Siesta Ste 204, 
San Diego, CA 
 (10.5 miles away)
858-514-3700
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ada Marin is a primary care provider, practicing in Family Medicine in San Diego, California. Dr. Marin is highly rated in 24 conditions, according to our data. Her clinical expertise encompasses Sialuria, PMM2-Congenital Disorder of Glycosylation, Phosphomannoisomerase Deficiency, and Sialic Acid Storage Disease.

Expertise in
25
conditions
Dr. Linda S. Falconio
Family Medicine
Expertise in
25
conditions
Dr. Linda S. Falconio
Family Medicine

Office

161 Thunder Dr Ste 102, 
Vista, CA 
 (29.6 miles away)
760-631-4000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Linda Falconio is a primary care provider, practicing in Family Medicine in Vista, California. Dr. Falconio is highly rated in 25 conditions, according to our data. Her clinical expertise encompasses Heterozygous Familial Hypercholesterolemia (HeFH), Homozygous Familial Hypercholesterolemia (HoFH), Hyperlipoproteinemia Type 4, and Familial Hypercholesterolemia.

Frequently Asked Questions about Dr. Mirwais Saifi

How do I make an appointment with Dr. Mirwais Saifi?

You can book an appointment with Dr. Mirwais Saifi by calling their office at 619-562-1140. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mirwais Saifi a top-rated expert for Insomnia?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mirwais Saifi is classified as an Advanced expert for Insomnia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mirwais Saifi specialize in?

While Dr. Mirwais Saifi is a Family Medicine, they have specific expertise in Insomnia, Familial Hypertension, and Hypertension. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Family Medicine.

Does Dr. Mirwais Saifi accept my insurance?

Dr. Mirwais Saifi accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 619-562-1140 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Saifi's expertise for a condition
ConditionClose
      View All 69 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile